| 1 |
33671159 | Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology. | 2021 Feb 17 |
1 |
| 2 |
34130375 | Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective. | 2021 Jun |
3 |
| 3 |
34340553 | The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. | 2021 Aug 31 |
2 |
| 4 |
32532094 | The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. | 2020 Jun 10 |
2 |